Literature DB >> 8211222

Red blood cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids.

N Mohandas1, J A Chasis.   

Abstract

An unusual combination of membrane properties allows the RBC to undergo extensive deformation without cell fragmentation, enabling it to effectively perform its function of oxygen delivery during its long life span in circulation. These material properties are the consequence of slow evolution-driven "engineering" which evolved a composite structure in which a plasma membrane envelope composed of amphiphilic surfactant molecules is anchored to a network of skeletal proteins through tethering sites (transmembrane proteins) in the bilayer. Explosive growth in our understanding of the primary structure of the various RBC membrane proteins, definition of specific mutations in various RBC phenotypes, and detailed biophysical characterization of membrane properties of normal and mutant RBCs has enabled development of models of the molecular and structural basis for RBC properties. In this review, we have attempted to synthesize all of this currently available information and define the contributions of various membrane components to different RBC properties.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8211222

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  91 in total

1.  Mapping of a spectrin-binding domain of human erythrocyte membrane protein 4.2.

Authors:  Debabrata Mandal; Prasun K Moitra; Joyoti Basu
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

2.  Mapping of a palmitoylatable band 3-binding domain of human erythrocyte membrane protein 4.2.

Authors:  R Bhattacharyya; A K Das; P K Moitra; B Pal; I Mandal; J Basu
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

3.  Atomic force microscopy demonstration of cytoskeleton instability in mouse erythrocytes with dematin-headpiece and β-adducin deficiency.

Authors:  Fei Liu; Anwar A Khan; Athar H Chishti; Agnes E Ostafin
Journal:  Scanning       Date:  2011-06-02       Impact factor: 1.932

4.  Micropipette aspiration of human erythrocytes induces echinocytes via membrane phospholipid translocation.

Authors:  G M Artmann; K L Sung; T Horn; D Whittemore; G Norwich; S Chien
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

5.  Elastic properties of the red blood cell membrane that determine echinocyte deformability.

Authors:  D Kuzman; S Svetina; R E Waugh; B Zeks
Journal:  Eur Biophys J       Date:  2003-09-12       Impact factor: 1.733

6.  Analysis of the mobilities of band 3 populations associated with ankyrin protein and junctional complexes in intact murine erythrocytes.

Authors:  Gayani C Kodippili; Jeff Spector; Jacob Hale; Katie Giger; Michael R Hughes; Kelly M McNagny; Connie Birkenmeier; Luanne Peters; Ken Ritchie; Philip S Low
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

7.  Tank-treading of erythrocytes in strong shear flows via a nonstiff cytoskeleton-based continuum computational modeling.

Authors:  W R Dodson; P Dimitrakopoulos
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

Review 8.  Particle margination and its implications on intravenous anticancer drug delivery.

Authors:  Erik Carboni; Katherine Tschudi; Jaewook Nam; Xiuling Lu; Anson W K Ma
Journal:  AAPS PharmSciTech       Date:  2014-04-02       Impact factor: 3.246

9.  Shape-Dependent Biodistribution of Biocompatible Silk Microcapsules.

Authors:  Sisi Cao; Rui Tang; Gail Sudlow; Zheyu Wang; Keng-Ku Liu; Jingyi Luan; Sirimuvva Tadepalli; Anushree Seth; Samuel Achilefu; Srikanth Singamaneni
Journal:  ACS Appl Mater Interfaces       Date:  2019-01-28       Impact factor: 9.229

10.  Effects of nitric oxide and its congeners on sickle red blood cell deformability.

Authors:  Andrea M Belanger; Christian Keggi; Tamir Kanias; Mark T Gladwin; Daniel B Kim-Shapiro
Journal:  Transfusion       Date:  2015-04-23       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.